Syapse experts Anna Berry, Mary Tran, and Michael Italia share how to establish high quality, real-world datasets by using a multi-source strategy.
A single source of data is often not enough to generate meaningful real-world evidence. Have you recently made an investment in a large raw real-world dataset, and are now drowning in data but lacking in evidence?
Watch as experts highlight strategic approaches you and your organization should consider as you invest in RWD to best capture the comprehensive patient journey needed to answer your most challenging questions, or seek to validate real-world endpoints.
Key Topics Include:
- Awareness on various RWD sources and their attributes, and how they are used to fill in the gaps to ensure your study design best reflects what is happening in the real-world
- Understanding whether artificial intelligence (AI) is a magical cure-all, or is it perpetuating inconsistencies or biases already in the data?
- How to take unstructured lab and pathology reports (including biomarker data) using NLP to ensure your study design best reflects what is happening in the real-world to generate more robust data
Presenters
Vice President
Molecular Pathology, Genomics and Laboratory Medicine
Syapse
Dr. Anna Berry is a thought leader in molecular oncology and personalized medicine, and experienced Scientific and Medical Director with a demonstrated history of working in the hospital & health care industry. Skilled in Oncology, Molecular Oncology, Molecular Biology, Healthcare Information Technology (HIT), and Healthcare Management.
SVP and GM, Data Insights
Data Insights
www.Syapse.com
Vice President
Product Development
Syapse
Michael Italia is focused on oncology precision medicine and real world evidence as VP of Product Development for Syapse. He leads teams to design and build complex, data-centric software applications in life science and healthcare.
Production Partner
Related Content
Practical AI: Adding Insight to the Patient Journey with Digital Phenotyping
In this webinar, Dr. Joseph Zabinski will discuss the digital phenotyping process and several concrete applications to demonstrate how AI can add value to analyses of the patient journey across the life sciences spectrum.
The Scientific and Operational Elegance of Study Replication with Real-World EHR Data: A Vitiligo and Alopecia Example
This webinar, hosted by experts from Panalgo and OM1, will look at the scientific and operational details behind study replication, using vitiligo and alopecia areata as an example.
Insights from the 2024 Salary Survey Report by HealthEconomics.com
Keep your finger on the economic pulse of the RWE, HEOR, and Market Access fields. This session focuses on the latest salary and bonus trends for professionals in the field, including a comprehensive overview of the ways industry, job level, location, demographics, and more factor into compensation.